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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idThe report by Mohamoud et al. is an informative, well executed
systematic review and meta-analysis on the prevalence of blood-
borne hepatitis C virus (HCV) in the Arabian Gulf countries. The
study stands as the ﬁrst to provide such comprehensive picture of
HCV epidemiology in this region. With the recent advances in HCV
treatment, this study comes at an important juncture, highlighting
critical gaps in research and priority avenues for prevention in a
region that is a melting pot of much of the Middle East and North
Africa (MENA). MENA stands, overall, as the region with the
highest HCV prevalence in the world.
A strength of the report was the authors’ ability to include all
available publications, some of which are from locally published
journals and country level reports. By providing an abundance of
details and descriptives in tables and ﬁgures, and conducting meta-
analytics to assess study effect sizes and heterogeneity, the study
establishes itself as an essential reference for HCV epidemiology in
this region.
Mohamoud et al. estimated that the overall prevalence of anti-
HCV antibody for the Arabian Gulf, was about 1% and the
prevalence of HCV RNA (diagnostic for HCV viremia and typically
two thirds of the antibody prevalence) to be lower. Higher HCV
prevalence was found in resident expatriates, especially Egyptians,
multi-transfused and dialysis patients, thalassemics, and people
who inject drugs.
A striking ﬁnding of this study was the dominant role of HCV
iatrogenic transmission. For example, the highest HCV estimates
were reported in attendees of hemodialysis and thalassemia
centers. This is an urgent issue that needs updated research studies
and follow-up; particularly given that this region has all the
resources needed for dedicated facilities and cohorting patients
which prevent HCV negative patients from becoming infected.
The authors found that the prevalence of HCV was typically
higher in reports that included non-nationals. These individuals
are more often than not immigrant workers to the region. This was
especially true of Egyptian nationals. Saudi Arabia and other Gulf
countries instigated a policy that all migrant workers have to be
tested free of HCV before a visa would be issued to live and work in
the country. This policy has been in place for more than a decade. It
would be useful to know when these infected foreign nationalshttp://dx.doi.org/10.1016/j.ijid.2016.03.009
1201-9712/ 2016 Published by Elsevier Ltd on behalf of International Society for Infect
creativecommons.org/licenses/by-nc-nd/4.0/).immigrated and if they had been screened. That said, there is no
public health justiﬁcation for this regional policy and it is not
endorsed by the World Health Organization nor practiced
elsewhere in the world. HCV screening for visa applications needs
to be stopped to end this discriminating practice against infected
persons.
The authors established that national and risk group estimates
were based, with too few exceptions, on convenience samples that
are susceptible to inherent bias. The few probability-based
sampling studies were limited to speciﬁc urban areas or selected
age groups. This highlights an important rationale for conducting
population-based studies to guide public health policy and
programs. In addition, further current epidemiological work is
needed as too few of the included publications were recent. This
begs for a recommendation in a region with ample resources, both
technical and monetary, to improve the health status of its
population: to design and complete full national-scale probability-
based epidemiologic investigations on viral hepatitis. This would
be an opportunity to include other important endemic pathogens
and health conditions. This could be integrated or paralleled with
maternal and childhood data collection, and nutritional and risk
factor surveys. The results would be invaluable and would, no
doubt, generate international scientiﬁc interest. This report by
Mohamoud et al. provides a solid basis for this recommendation
and points to the needed quality and standards for conducting HCV
epidemiologic studies in these communities.
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